Huadong Medicine

Huadong Medicine is one of the...

• CSI 300.

Huadong Medicine is a company listed under the stock ticker 000963 (CN).

View the org chart displaying its 13 main executives

Most searched biographies at Huadong Medicine

• Liang Lu, Chairman of the Board and Chief Executive Officer
• Ruwei Wang, Independent Director
• Feipeng Zhu, Director

Create your alert
to follow the executive moves at Huadong Medicine.

Huadong Medicine has 1,868 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Huadong Medicine

Social media about Huadong Medicine

• Huadong Medicine on Wikipedia, Google News & Yahoo Finance
• Huadong Medicine on LinkedIn, Twitter & YouTube

Call Huadong Medicine at +86 571 ...

View the org chart

Register to receive your alert

Report an error